Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review
Pediatric Anesthesia · 2024
DOI: 10.1111/pan.14970 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Pediatric Anesthesia, 2024. Verfasst von Joseph D Tobias. Beteiligte Einrichtung: Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA. Hauptthemen laut MEDLINE: Benzodiazepines, Hypnotics and Sedatives. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 57 Literaturangaben.
Abstract (Originalsprache)
Remimazolam is a novel ultrashort‐acting benzodiazepine, which like midazolam, results in sedation, anxiolysis, and amnesia through its agonistic effects on the gamma‐amino butyric acid A receptor. As opposed to midazolam, its unique metabolism is via tissue esterases, which results in a rapid elimination with a limited context sensitive half‐life and prompt dissipation of its effect when administration is discontinued. Remimazolam received FDA approval for use in adults in 2020. In preliminary and initial clinical trials, its efficacy and safety has been suggested in the adult population, both as a primary agent for procedural sedation or as an adjunct to general anesthesia. There are limited data regarding the use of remimazolam in infants and children and its use in this population remains off label as it does not hold FDA ‐approval in pediatric‐aged patients. This narrative outlines the pharmacologic properties of this unique medication, reviews previous published reports of its role in pediatric‐aged patients, and discusses dosing parameters and clinical use in this population.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Anesthesiology and Pain Medicine, Nationwide Children's Hospital, Columbus, Ohio, USA.
- Department of Anesthesiology and Pain Medicine, The Ohio State University College of Medicine, Columbus, Ohio, USA.
- Department of Pediatrics, The Ohio State University College of Medicine, Columbus, Ohio, USA.
ORCID-Profile: Joseph D Tobias
Zitieren
APA
Tobias, J. D. (2024). Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review. Pediatric Anesthesia. https://doi.org/10.1111/pan.14970
Vancouver
Tobias JD. Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review. Pediatric Anesthesia. 2024. doi:10.1111/pan.14970
BibTeX
@article{Tobias2024,
author = {Tobias, Joseph D},
title = {Clinical experience with remimazolam in pediatric anesthesiology: An educational focused review},
journal = {Pediatric Anesthesia},
year = {2024},
doi = {10.1111/pan.14970}
}
EUVIMED